Corneal Persistent Epithelial Defect clinical trials at UCLA

1 in progress, 0 open to eligible people

KPI-012 Ophthalmic Solution in Participants With PCED
Sorry, in progress, not accepting new patients
The primary objective of the study is to investigate the safety and efficacy of KPI-012 compared to vehicle in participants who have a documented clinical diagnosis of PCED.
Los Angeles 5368361, California 5332921 and other locations

Last updated: September 26, 2025